Efficacy and safety of Ivarmacitinib in moderate-to-severe atopic dermatitis patients with or without previous systemic treatments: a post-hoc analysis of a phase III trial
1. 系统已在2026-07-09 17:22:44对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1080/09546634.2025.2591478
文献链接: https://www.tandfonline.com/doi/full/10.1080/09546634.2025.2591478
其他信息:
出版社: Informa UK Limited
作者: Qingchun Diao; Ruiling Jia; Min Li; Peng Zhao; Fang Lu; Qin Zhang; Chunzhu Ning; Juan Long; Jiajia Li; Yan Huang; Yuyi Wang

